This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This review highlights the emerging role of new therapies in advanced lung cancer versus conventional treatment
This page is a summary of: Do we need Maintenance Chemotherapy in advanced NSCLC in the Era of Immune and Targeted Therapy?, Current Cancer Therapy Reviews, April 2018, Bentham Science Publishers,
DOI: 10.2174/1573394714666180417160205.
You can read the full text:
The following have contributed to this page
Therapeutic Advances in Endocrinology and Metabolism
Weight gain induced Insulin Resistance leads to compensatory Insulin hypersecretion. So obese Type 2 Diabetes patients have increased fasting insulin levels. But non-obese Indians suffering from Ty...
Journal of Pharmaceutical Innovation
Fractal geometry is a relatively young and promesing mathematical concept. The focus of this article lies on using this powerful tool for monitoring and forecasting the water solubility of dihydroq...
Letters in Drug Design & Discovery
This study focuses on finding new drugs to treat cancer by targeting specific proteins called CDK 4/6, which are crucial for cancer cell growth. Using advanced computer simulations, researchers scr...
